Hsu Han-Tung, Yu-Chuan Kang Eugene, Blair Michael P, Shapiro Michael, Komati Rahul, Hubbard Baker G, Price Kenneth W, Capone Antonio, Drenser Kim A, Trese Michael T, Shields Ryan, Kondo Hiroyuki, Matsushita Itsuka, Yonekawa Yoshihiro, Patel Samir N, Kusaka Shunji, Mano Fukutaro, Olsen Karl R, Ells Anna, Amphornphruet Atchara, Walsh Mark K, Besirli Cagri G, Moinuddin Omar, Baumal Caroline R, Enriquez Ana Bety, Hwang Yih-Shiou, Lai Chi-Chun, Wu Wei-Chi
Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan, Taiwan; College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Ophthalmol Retina. 2023 Jan;7(1):72-80. doi: 10.1016/j.oret.2022.07.005. Epub 2022 Jul 16.
To investigate late vitreoretinal complications and visual outcomes in patients with regressed retinopathy of prematurity (ROP) with or without prior treatment.
International, multicenter, noncomparative retrospective case series.
We analyzed 264 eyes of 238 patients from 13 centers worldwide who developed vitreoretinal complications (retinal detachment [RD], vitreous hemorrhage [VH], or retinal break) ≥ 2 years after resolution of acute ROP.
Each participant was assigned to 1 of 3 groups (the RD, VH, and retinal break groups) according to their primary diagnosis. The average age at presentation, visual acuities, refractive error, axial length, gestational age, birth weight, acute ROP classification, prior treatments for acute ROP, postoperative visual acuity (VA), and concomitant eye conditions in the 3 groups were documented and compared.
Clinical features and visual outcomes of late vitreoretinal complications in patients with regressed ROP.
A total of 264 eyes of 238 patients were included. The prior acute ROP status was comparable among the 3 groups, except that the VH group had a higher proportion of patients with type 1 ROP (P = 0.03) and prior treatment (P < 0.001) than the other groups. The average age at presentation was earlier in the RD (20.3 ± 15.5 years) and VH (21.4 ± 18.9 years) groups than in the retinal break group (31.9 ± 18.2 years; P < 0.001). The retinal break group had the best presenting best-corrected VA, followed by the RD and VH groups (P < 0.001). Surgical intervention improved VA in both the RD and VH groups (both P < 0.05). The overall trend of VA was the most favorable in the retinal break group, followed by that in the VH and RD groups. Cicatricial changes in the fellow retina were observed in > 90% of patients with unilateral involvement.
Infants with acute ROP remain at a high risk of vision-threatening complications throughout childhood and adulthood. Continual follow-up of patients with ROP is important. When severe complications, such as RD or VH, are detected, timely surgical intervention is necessary to ensure favorable visual outcomes in these patients.
研究既往有或无治疗史的早产儿视网膜病变(ROP)消退患者的晚期玻璃体视网膜并发症及视觉预后。
国际多中心非对照回顾性病例系列研究。
我们分析了来自全球13个中心的238例患者的264只眼,这些患者在急性ROP消退后≥2年出现玻璃体视网膜并发症(视网膜脱离[RD]、玻璃体积血[VH]或视网膜裂孔)。
根据主要诊断将每位参与者分为3组(RD组、VH组和视网膜裂孔组)中的1组。记录并比较3组患者的就诊时平均年龄、视力、屈光不正、眼轴长度、孕周、出生体重、急性ROP分级、急性ROP的既往治疗情况、术后视力(VA)及合并眼部情况。
ROP消退患者晚期玻璃体视网膜并发症的临床特征及视觉预后。
共纳入238例患者的264只眼。3组患者既往急性ROP状态具有可比性,但VH组1型ROP患者比例(P = 0.03)及既往治疗比例(P < 0.001)高于其他组。RD组(20.3±15.5岁)和VH组(21.4±18.9岁)的就诊时平均年龄早于视网膜裂孔组(31.9±18.2岁;P < 0.001)。视网膜裂孔组就诊时最佳矫正视力最佳,其次是RD组和VH组(P < 0.001)。手术干预改善了RD组和VH组的视力(均P < 0.05)。视力总体趋势在视网膜裂孔组最有利,其次是VH组和RD组。单侧受累患者中> 90%的对侧视网膜出现瘢痕改变。
急性ROP患儿在整个儿童期和成年期仍面临视力威胁性并发症的高风险。对ROP患者进行持续随访很重要。当检测到严重并发症,如RD或VH时,及时手术干预对于确保这些患者获得良好的视觉预后是必要的。